On Demand March 5, 2008

Return to On Demand Menu

Cardiometabolic Syndrome: Understanding Risk and Treatment

Broadcast Date: March 5, 2008
(2 hours)


View Program


Myrtle E. Goore, MD (8 pages)
Beverly Stoudemire-Howlett, MD
(11 pages, 1.1 MB)
Terri Klose, RN, RD (13 pages, 1.5 MB)

Choose Player

RealPlayerYou will need RealPlayer to view this file.
Windows Media PlayerYou will need Windows Media Player to view this file.

Program Overview

The growing prevalence of the cardiometabolic syndrome (CMS) has been related to obesity, which has increased among many age groups. It is currently accepted that CMS predicts cardiovascular mortality and/or the development of type 2 diabetes mellitus. CMS is further complicated by modifications in body composition and fat redistribution and is often associated with altered insulin sensitivity. The primary goal of clinical management of the metabolic syndrome is to reduce the risk for type 2 diabetes and cardiovascular disease.

For more information, view the conference flyer.

Target Audience

Physicians, nurse practitioners, nurses, physician assistants, pharmacists, dietitians and social workers.

Contact Hours

None for this program

Contact for Technical Assistance

334-206-5618 or email ALPHTN

Back to Top

Page last updated: April 5, 2017